Ribonucleotide Reductases
"Ribonucleotide Reductases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D012264
|
MeSH Number(s) |
D08.811.682.810
|
Concept/Terms |
Ribonucleotide Reductases- Ribonucleotide Reductases
- Reductases, Ribonucleotide
- Ribonucleotide Reductase
- Reductase, Ribonucleotide
|
Below are MeSH descriptors whose meaning is more general than "Ribonucleotide Reductases".
Below are MeSH descriptors whose meaning is more specific than "Ribonucleotide Reductases".
This graph shows the total number of publications written about "Ribonucleotide Reductases" by people in this website by year, and whether "Ribonucleotide Reductases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ribonucleotide Reductases" by people in Profiles.
-
Dassama LM, Jiang W, Varano PT, Pandelia ME, Conner DA, Xie J, Bollinger JM, Krebs C. Radical-translocation intermediates and hurdling of pathway defects in "super-oxidized" (Mn(IV)/Fe(IV)) Chlamydia trachomatis ribonucleotide reductase. J Am Chem Soc. 2012 Dec 19; 134(50):20498-506.
-
Jiang W, Xie J, Varano PT, Krebs C, Bollinger JM. Two distinct mechanisms of inactivation of the class Ic ribonucleotide reductase from Chlamydia trachomatis by hydroxyurea: implications for the protein gating of intersubunit electron transfer. Biochemistry. 2010 Jun 29; 49(25):5340-9.
-
Burkhalter MD, Roberts SA, Havener JM, Ramsden DA. Activity of ribonucleotide reductase helps determine how cells repair DNA double strand breaks. DNA Repair (Amst). 2009 Nov 2; 8(11):1258-63.
-
Masters GA, Argiris AE, Hahn EA, Beck JT, Rausch PG, Ye Z, Monberg MJ, Bloss LP, Curiel RE, Obasaju CK. A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer. J Thorac Oncol. 2006 Jan; 1(1):19-24.